Literature DB >> 24940289

3-Methyl-sulfanyl-5-phenyl-1,2,4-triazine.

Salha Hamri1, Abderrafia Hafid1, Mostafa Khouili1, Lahcen El Ammari2, El Mostafa Ketatni3.   

Abstract

In the mol-ecule of the title compound, C10H9N3S, the dihedral angle between the triazine and phenyl rings is 11.77 (7)°. In the crystal, mol-ecules are linked by π-π stacking inter-actions [centroid-centroid distances = 3.7359 (3) and 3.7944 (4) Å], forming layers parallel to the bc plane.

Entities:  

Year:  2014        PMID: 24940289      PMCID: PMC4051076          DOI: 10.1107/S1600536814011830

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For the biological activity of sulfonamides, see: Abd el-Samii (1992 ▶); Kidwai et al. (1998 ▶); Holla et al. (2001 ▶); Abdel-Rahman et al. (1999 ▶); Hay et al. (2004 ▶); Sztanke et al. (2005 ▶). For the structure of a similar compound, see: Wen et al. (2006 ▶).

Experimental

Crystal data

C10H9N3S M = 203.26 Monoclinic, a = 7.7513 (3) Å b = 12.9191 (5) Å c = 9.8262 (3) Å β = 94.584 (2)° V = 980.85 (6) Å3 Z = 4 Mo Kα radiation μ = 0.29 mm−1 T = 296 K 0.41 × 0.35 × 0.29 mm

Data collection

Bruker X8 APEX diffractometer Absorption correction: multi-scan (SADABS; Bruker, 2009 ▶) T min = 0.693, T max = 0.747 15588 measured reflections 2859 independent reflections 2544 reflections with I > 2σ(I) R int = 0.023

Refinement

R[F 2 > 2σ(F 2)] = 0.037 wR(F 2) = 0.110 S = 1.10 2859 reflections 127 parameters H-atom parameters constrained Δρmax = 0.32 e Å−3 Δρmin = −0.24 e Å−3 Data collection: APEX2 (Bruker, 2009 ▶); cell refinement: SAINT (Bruker, 2009 ▶); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ▶); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008 ▶); molecular graphics: ORTEP-3 for Windows (Farrugia, 2012 ▶); software used to prepare material for publication: PLATON (Spek, 2009 ▶) and publCIF (Westrip, 2010 ▶). Crystal structure: contains datablock(s) I. DOI: 10.1107/S1600536814011830/rz5126sup1.cif Structure factors: contains datablock(s) I. DOI: 10.1107/S1600536814011830/rz5126Isup2.hkl Click here for additional data file. Supporting information file. DOI: 10.1107/S1600536814011830/rz5126Isup3.cml CCDC reference: 1004529 Additional supporting information: crystallographic information; 3D view; checkCIF report
C10H9N3SF(000) = 424
Mr = 203.26Dx = 1.376 Mg m3
Monoclinic, P21/cMo Kα radiation, λ = 0.71073 Å
Hall symbol: -P 2ybcCell parameters from 2859 reflections
a = 7.7513 (3) Åθ = 2.6–30.0°
b = 12.9191 (5) ŵ = 0.29 mm1
c = 9.8262 (3) ÅT = 296 K
β = 94.584 (2)°Block, yellow
V = 980.85 (6) Å30.41 × 0.35 × 0.29 mm
Z = 4
Bruker X8 APEX diffractometer2859 independent reflections
Radiation source: fine-focus sealed tube2544 reflections with I > 2σ(I)
Graphite monochromatorRint = 0.023
φ and ω scansθmax = 30.0°, θmin = 2.6°
Absorption correction: multi-scan (SADABS; Bruker, 2009)h = −10→10
Tmin = 0.693, Tmax = 0.747k = −18→16
15588 measured reflectionsl = −11→13
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.037Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.110H-atom parameters constrained
S = 1.10w = 1/[σ2(Fo2) + (0.0567P)2 + 0.210P] where P = (Fo2 + 2Fc2)/3
2859 reflections(Δ/σ)max = 0.001
127 parametersΔρmax = 0.32 e Å3
0 restraintsΔρmin = −0.24 e Å3
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against all reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on all data will be even larger.
xyzUiso*/Ueq
S0.23977 (4)0.83039 (3)0.60310 (3)0.04391 (12)
N10.55958 (14)0.87884 (9)0.70043 (10)0.0411 (2)
N20.49883 (12)0.86358 (7)0.45807 (9)0.0321 (2)
N30.72612 (15)0.90131 (11)0.68242 (11)0.0492 (3)
C10.2219 (2)0.83401 (12)0.78375 (15)0.0478 (3)
H1A0.10530.81760.80250.072*
H1B0.25090.90200.81770.072*
H1C0.29970.78440.82780.072*
C20.45673 (14)0.86159 (8)0.58822 (11)0.0315 (2)
C30.77637 (16)0.90344 (12)0.55773 (13)0.0434 (3)
H30.89150.91880.54610.052*
C40.66358 (14)0.88349 (8)0.44103 (11)0.0308 (2)
C50.72027 (15)0.88557 (8)0.30105 (11)0.0324 (2)
C60.89529 (17)0.88858 (11)0.27791 (14)0.0439 (3)
H60.97850.88870.35150.053*
C70.9461 (2)0.89133 (13)0.14577 (16)0.0537 (4)
H71.06310.89390.13110.064*
C80.8234 (2)0.89027 (12)0.03593 (15)0.0539 (4)
H80.85760.8917−0.05260.065*
C90.6501 (2)0.88713 (12)0.05779 (13)0.0499 (3)
H90.56770.8863−0.01640.060*
C100.59717 (17)0.88521 (10)0.18942 (12)0.0403 (3)
H100.47990.88370.20320.048*
U11U22U33U12U13U23
S0.03440 (17)0.0619 (2)0.03562 (17)−0.00433 (12)0.00418 (12)0.00196 (13)
N10.0413 (5)0.0550 (6)0.0266 (4)−0.0031 (4)0.0003 (4)0.0005 (4)
N20.0327 (4)0.0367 (5)0.0264 (4)−0.0001 (3)0.0000 (3)0.0010 (3)
N30.0410 (6)0.0750 (8)0.0305 (5)−0.0083 (5)−0.0042 (4)−0.0019 (5)
C10.0498 (7)0.0555 (8)0.0397 (7)−0.0018 (6)0.0137 (5)0.0043 (5)
C20.0339 (5)0.0325 (5)0.0280 (5)0.0015 (4)0.0020 (4)0.0023 (4)
C30.0328 (5)0.0640 (8)0.0324 (6)−0.0063 (5)−0.0023 (4)−0.0007 (5)
C40.0330 (5)0.0318 (5)0.0271 (5)0.0006 (4)−0.0003 (4)0.0008 (4)
C50.0374 (5)0.0321 (5)0.0280 (5)0.0004 (4)0.0033 (4)−0.0002 (4)
C60.0389 (6)0.0537 (7)0.0396 (6)0.0064 (5)0.0060 (5)0.0013 (5)
C70.0509 (8)0.0642 (9)0.0485 (8)0.0080 (7)0.0197 (6)0.0016 (7)
C80.0753 (10)0.0539 (8)0.0350 (6)0.0041 (7)0.0192 (6)−0.0014 (6)
C90.0675 (9)0.0546 (8)0.0271 (5)−0.0046 (6)−0.0002 (5)−0.0023 (5)
C100.0443 (6)0.0467 (6)0.0294 (5)−0.0060 (5)−0.0006 (4)−0.0012 (5)
S—C21.7469 (11)C4—C51.4773 (15)
S—C11.7921 (14)C5—C61.3939 (17)
N1—C21.3268 (15)C5—C101.3951 (16)
N1—N31.3486 (16)C6—C71.3872 (18)
N2—C41.3263 (14)C6—H60.9300
N2—C21.3451 (14)C7—C81.381 (2)
N3—C31.3153 (17)C7—H70.9300
C1—H1A0.9600C8—C91.378 (2)
C1—H1B0.9600C8—H80.9300
C1—H1C0.9600C9—C101.3880 (17)
C3—C41.4091 (15)C9—H90.9300
C3—H30.9300C10—H100.9300
C2—S—C1103.19 (6)C6—C5—C10119.03 (11)
C2—N1—N3116.42 (10)C6—C5—C4121.21 (10)
C4—N2—C2115.65 (9)C10—C5—C4119.76 (11)
C3—N3—N1118.99 (10)C7—C6—C5120.43 (13)
S—C1—H1A109.5C7—C6—H6119.8
S—C1—H1B109.5C5—C6—H6119.8
H1A—C1—H1B109.5C8—C7—C6120.11 (14)
S—C1—H1C109.5C8—C7—H7119.9
H1A—C1—H1C109.5C6—C7—H7119.9
H1B—C1—H1C109.5C9—C8—C7119.87 (12)
N1—C2—N2127.71 (10)C9—C8—H8120.1
N1—C2—S119.19 (9)C7—C8—H8120.1
N2—C2—S113.10 (8)C8—C9—C10120.68 (13)
N3—C3—C4122.93 (11)C8—C9—H9119.7
N3—C3—H3118.5C10—C9—H9119.7
C4—C3—H3118.5C9—C10—C5119.88 (13)
N2—C4—C3118.28 (10)C9—C10—H10120.1
N2—C4—C5118.82 (10)C5—C10—H10120.1
C3—C4—C5122.89 (10)
  6 in total

1.  Synthesis of heterobicyclic nitrogen systems bearing the 1,2,4-triazine moiety as anti-HIV and anticancer drugs: Part I.

Authors:  R M Abdel-Rahman; J M Morsy; F Hanafy; H A Amene
Journal:  Pharmazie       Date:  1999-05       Impact factor: 1.267

2.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

3.  Synthesis of some new biologically active bis-(thiadiazolotriazines) and bis-(thiadiazolotriazinyl) alkanes.

Authors:  B S Holla; R Gonsalves; B S Rao; S Shenoy; H N Gopalakrishna
Journal:  Farmaco       Date:  2001-12

4.  Antinociceptive activity of new imidazolidine carbonyl derivatives. Part 4. Synthesis and pharmacological activity of 8-aryl-3,4-dioxo-2H,8H-6,7-dihydroimidazo[2,1-c] [1,2,4]triazines.

Authors:  Krzysztof Sztanke; Sylwia Fidecka; Ewa Kedzierska; Zbigniew Karczmarzyk; Kalevi Pihlaja; Dariusz Matosiuk
Journal:  Eur J Med Chem       Date:  2005-02       Impact factor: 6.514

5.  Synthesis and anti-inflammatory activity of some novel 1,3,4-oxadiazole derivatives.

Authors:  Z K Abd el-Samii
Journal:  J Chem Technol Biotechnol       Date:  1992       Impact factor: 3.174

6.  Structure validation in chemical crystallography.

Authors:  Anthony L Spek
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-01-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.